These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3036259

  • 1. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J, Insel TR.
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [Abstract] [Full Text] [Related]

  • 2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 3. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR.
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [Abstract] [Full Text] [Related]

  • 4. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL.
    Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
    [Abstract] [Full Text] [Related]

  • 5. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 6. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of obsessive-compulsive disorder.
    Klein DF.
    Encephale; 1990 Feb 01; 16 Spec No():331-4. PubMed ID: 2209491
    [Abstract] [Full Text] [Related]

  • 8. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug 01; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 9. Tricyclic response in obsessive compulsive disorder.
    Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Aug 01; 9(1):25-31. PubMed ID: 3991911
    [Abstract] [Full Text] [Related]

  • 10. New pharmacologic approaches to obsessive compulsive disorder.
    Insel TR.
    J Clin Psychiatry; 1990 Oct 01; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
    [Abstract] [Full Text] [Related]

  • 11. Drug treatment of obsessive-compulsive disorder.
    Zohar J, Insel TR.
    J Affect Disord; 1987 Oct 01; 13(2):193-202. PubMed ID: 2960711
    [Abstract] [Full Text] [Related]

  • 12. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M, Turner SM, Michelson L, Jacob R.
    Am J Psychiatry; 1985 May 01; 142(5):572-6. PubMed ID: 3885761
    [Abstract] [Full Text] [Related]

  • 13. Biological markers in obsessive-compulsive and affective disorders.
    Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL.
    J Psychiatr Res; 1984 May 01; 18(4):407-23. PubMed ID: 6512711
    [Abstract] [Full Text] [Related]

  • 14. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA, Fineberg NA, Montgomery D.
    Encephale; 1990 May 01; 16 Spec No():335-9. PubMed ID: 2209492
    [Abstract] [Full Text] [Related]

  • 15. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB, Steketee G, Kozak MJ, Dugger D.
    Psychiatry Res; 1987 Jun 01; 21(2):123-36. PubMed ID: 3615688
    [Abstract] [Full Text] [Related]

  • 16. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
    Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH.
    Biol Psychiatry; 1991 Aug 01; 30(3):225-32. PubMed ID: 1832972
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
    Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL.
    Arch Gen Psychiatry; 1993 Jun 01; 50(6):441-7. PubMed ID: 8498878
    [Abstract] [Full Text] [Related]

  • 18. The antiobsessional effects of clomipramine do not require concomitant affective disorder.
    Katz RJ, DeVeaugh-Geiss J.
    Psychiatry Res; 1990 Feb 01; 31(2):121-9. PubMed ID: 2183254
    [Abstract] [Full Text] [Related]

  • 19. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD.
    Arch Gen Psychiatry; 1989 Dec 01; 46(12):1088-92. PubMed ID: 2686576
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.
    Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL.
    Biol Psychiatry; 1993 Jan 01; 33(1):3-14. PubMed ID: 8420593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.